Curtailing side effects in chemotherapy: a tale of PKCδ in cisplatin treatment
about
Wee1 inhibition potentiates Wip1-dependent p53-negative tumor cell death during chemotherapyA meta-analysis comparing cisplatin-based to carboplatin-based chemotherapy in moderate to advanced squamous cell carcinoma of head and neck (SCCHN).A strategy for integrating essential three-dimensional microphysiological systems of human organs for realistic anticancer drug screening.Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance.Potent organo-osmium compound shifts metabolism in epithelial ovarian cancer cells.Antitumor potential of the myotoxin BthTX-I from Bothrops jararacussu snake venom: evaluation of cell cycle alterations and death mechanisms induced in tumor cell lines.Epoxyeicosatrienoic acids prevent cisplatin-induced renal apoptosis through a p38 mitogen-activated protein kinase-regulated mitochondrial pathway.CXCL16 regulates cisplatin-induced acute kidney injury.The predictive value of 53BP1 and BRCA1 mRNA expression in advanced non-small-cell lung cancer patients treated with first-line platinum-based chemotherapy.Aptamer-guided DNA tetrahedron as a novel targeted drug delivery system for MUC1-expressing breast cancer cells in vitro.Pre-clinical efficacy and synergistic potential of the MDM2-p53 antagonists, Nutlin-3 and RG7388, as single agents and in combined treatment with cisplatin in ovarian cancer.Probenecid Sensitizes Neuroblastoma Cancer Stem Cells to Cisplatin.Quercetin and hyperthermia modulate cisplatin-induced DNA damage in tumor and normal tissues in vivo.DNA damage response in nephrotoxic and ischemic kidney injury.Melanoma tumor inhibition by tetrachlorido(O,O'-dibutyl-ethylenediamine-N,N'-di-3-propionate)platinum(IV) complex: in vitro and in vivo investigations.Cyclotherapy: opening a therapeutic window in cancer treatment.Competing Actions of Type 1 Angiotensin II Receptors Expressed on T Lymphocytes and Kidney Epithelium during Cisplatin-Induced AKI.Ethanolic Neem (Azadirachta indica) Leaf Extract Prevents Growth of MCF-7 and HeLa Cells and Potentiates the Therapeutic Index of Cisplatin.Mechanical stress promotes cisplatin-induced hepatocellular carcinoma cell death.Hsa-miR-132 regulates apoptosis in non-small cell lung cancer independent of acetylcholinesterase.Effects of Cornus mas fruit hydro-methanolic extract on serum antioxidants, lipid profile, and hematologic parameters following cisplatin-induced changes in rats.Protein Kinase Cδ Suppresses Autophagy to Induce Kidney Cell Apoptosis in Cisplatin Nephrotoxicity.Immunotherapies: Exploiting the Immune System for Cancer Treatment.Cellular Pharmacology of Palladinum(III) Hematoporphyrin IX Complexes: Solution Stability, Antineoplastic and Apoptogenic Activity, DNA Binding, and Processing of DNA-Adducts
P2860
Q28833606-61F020F8-DF9E-469B-BCB1-BF955DFC774DQ33429085-5AED6C51-0FB3-4F09-B70B-82EC3D971FC4Q34143251-8E5AAD5D-C225-4C19-9E93-BECFFBDEB0A8Q34307356-45FCF82E-267C-4983-8B40-3811802F7B83Q35895492-D38E3F93-082D-42C9-AF0F-450895DD2BD2Q36246909-A199B6A1-9D1D-4B7D-BEE8-FE2529A389DAQ37325638-3B2A4EFE-9833-4A75-AE14-0BB0AB180407Q37362481-FCA0F462-7357-4832-A14A-748070B86128Q37381571-6BA44323-A87C-45B2-9AF9-6928D773D104Q37437464-54DBCC50-558B-4C3D-984A-570AF538CD74Q37457809-A6F41339-B7A9-4542-80D5-238C52870387Q38787387-F157C33C-39A1-4820-8A66-94504B4C088BQ39010109-E4C81FD2-A1C2-4D6D-BC8E-6E40F49159CEQ39041331-6F60A23A-FC8C-492D-BF6B-B3C271B640B0Q39270889-ADEF5766-A24D-4AF1-9C2E-C9DA6529917FQ39328882-F014659E-96C3-441B-95B2-CA59C8FE9E6BQ41885649-12451632-16FC-457B-A516-36AF2ED2ABF5Q41966079-05CBF2FA-AC38-4C48-B23F-C27C6E473290Q42032584-1E6E2CD9-8932-415A-8819-6E6602BEAAF1Q44759115-C4535ECB-C4C4-403B-8C4E-D3FA789B4220Q47121686-3F5E6A41-40FD-4FA1-8236-06D42ABFA119Q48037609-E0A339A7-9E02-430D-AA6D-536A7FE49E0FQ55362851-77BFA125-E990-44DD-BEB3-AA80C334EF68Q58766014-2A7F3555-8A53-4364-85FC-82EE59651DF2
P2860
Curtailing side effects in chemotherapy: a tale of PKCδ in cisplatin treatment
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Curtailing side effects in chemotherapy: a tale of PKCδ in cisplatin treatment
@ast
Curtailing side effects in chemotherapy: a tale of PKCδ in cisplatin treatment
@en
Curtailing side effects in chemotherapy: a tale of PKCδ in cisplatin treatment
@nl
type
label
Curtailing side effects in chemotherapy: a tale of PKCδ in cisplatin treatment
@ast
Curtailing side effects in chemotherapy: a tale of PKCδ in cisplatin treatment
@en
Curtailing side effects in chemotherapy: a tale of PKCδ in cisplatin treatment
@nl
prefLabel
Curtailing side effects in chemotherapy: a tale of PKCδ in cisplatin treatment
@ast
Curtailing side effects in chemotherapy: a tale of PKCδ in cisplatin treatment
@en
Curtailing side effects in chemotherapy: a tale of PKCδ in cisplatin treatment
@nl
P2860
P921
P356
P1433
P1476
Curtailing side effects in chemotherapy: a tale of PKCδ in cisplatin treatment
@en
P2093
Navjotsingh Pabla
Zheng Dong
P2860
P304
P356
10.18632/ONCOTARGET.439
P407
P5008
P577
2012-01-01T00:00:00Z